drugset
drugset / Trial / NCT05160389

A Study to Assess the Effect of Food on the Absorption and Bioavailability of PBI-200

NCT05160389 ↗

Phase 1 Completed 16 enrolled Pyramid Biosciences
RandomizedCrossoverOpen-labelTreatment

Summary

This is a single-dose, open-label, randomized, three-way crossover study to assess the effect of food on the absorption and bioavailability of PBI-200.

Timeline

Start
2021-11-17
Primary completion
2022-01-06
Completion
2022-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PALTIMATRECTINIB Small molecule — Oral

Indications

No indication recorded.